BnR Summit 2026

Belt & Road Summit - Deal-Making 2026

9 – 15 Sept 2026 | Hong Kong, China (Hong Kong)

ProjectUpdated on 24 August 2026

Focusing on microRNA drug development and PDEV delivery system

Director at Golden Biotech Limited

China (Hong Kong)

About

Golden Biotech, founded by Professor Yangchao Chen's team from the Faculty of Medicine at CUHK, is a company based at Hong Kong Science Park and dedicated to the R&D of innovative RNA‑based drugs, utilizing extracellular vesicles as a delivery system. The company’s proprietary PDEV platform is a natural, biocompatible nanocarrier enabling targeted and sustained delivery. Its therapeutic pipeline covers lung cancer, COPD, rhinitis, eye diseases, and hair loss. In parallel, the same PDEV technology is applied to skincare products and intimate care gels.

Project Location

  • China (Hong Kong)

Project Format

  • Private Project

Go Global Project

  • Yes

ESG (Environmental, Social, and Governance)

  • No

Project Stage

  • Operations

Main Project Sector

  • Technology

Type(s) of Last Financing Round of the project (if Applicable)

  • Equity (private)

Main Service(s) Required

  • Information Technology Services
  • Transportation Services

Attached files

Similar opportunities